RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Takeda Pharmaceutical Company Limited

A collection of news and information related to Takeda Pharmaceutical Company Limited published by this site and its partners.

Top Takeda Pharmaceutical Company Limited Articles see all

Displaying items 1-5
  • Chicago looks to Israel for tech startup lessons

    Chicago looks to Israel for tech startup lessons
    The rooftop deck atop Nir Zohar's Israeli startup firm provides a bird's-eye view of this metro area's evolution into a high-tech powerhouse.
  • Bill Harrison, Jackie Feldman Form PR Firm Third Street Media Group

    Public relations vets Bill Harrison and Jackie Feldman have launched new praisery Third Street Media Group that will focus on representing entertainment clients, consumer and lifestyle brands. Warner Bros. Television Group's Alloy Entertainment, online...

    Chicago health tech hub accepting applications, names leaders

    Chicago health tech hub accepting applications, names leaders
    Matter, a not-for-profit health tech hub in downtown Chicago slated to open in early 2015, on Tuesday named a chief executive and said it's taking applications for new tenants. “What's been missing here in this (health technology) community is a...

    Takeda and Eli Lilly ordered to pay $9 billion over Actos drug

    A federal jury awarded a combined $9 billion in punitive damages against Takeda Pharmaceuticals U.S.A. Inc. and Eli Lilly & Co. after it found that the drug makers did not disclose cancer risks for their diabetes medicine, Actos. The jury in Lafayette,...

    Diet drug Contrave to get another shot at FDA approval

    Diet drug Contrave to get another shot at FDA approval
    The makers of the proposed weight-loss drug Contrave said this week they have taken a key first step in showing that the medication does not boost the heart and stroke risks of those taking it, and they announced plans to return to the Food and Drug...